Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.
|
Blood
|
2005
|
6.07
|
2
|
Successes and challenges of HIV prevention in men who have sex with men.
|
Lancet
|
2012
|
4.94
|
3
|
Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study.
|
Lancet Infect Dis
|
2011
|
4.72
|
4
|
AIDS. Promote HIV chemoprophylaxis research, don't prevent it.
|
Science
|
2005
|
4.44
|
5
|
Factors associated with self-efficacy for condom use and sexual negotiation among South african youth.
|
J Acquir Immune Defic Syndr
|
2006
|
2.21
|
6
|
Social networking technologies as an emerging tool for HIV prevention: a cluster randomized trial.
|
Ann Intern Med
|
2013
|
1.97
|
7
|
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.
|
Blood
|
2009
|
1.83
|
8
|
HIV-related stigma, social norms, and HIV testing in Soweto and Vulindlela, South Africa: National Institutes of Mental Health Project Accept (HPTN 043).
|
J Acquir Immune Defic Syndr
|
2010
|
1.78
|
9
|
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.
|
Br J Haematol
|
2007
|
1.77
|
10
|
The relationship between online social networking and sexual risk behaviors among men who have sex with men (MSM).
|
PLoS One
|
2013
|
1.74
|
11
|
Linkage to HIV care and survival following inpatient HIV counseling and testing.
|
AIDS Behav
|
2011
|
1.66
|
12
|
Antiretroviral drug resistance, HIV-1 tropism, and HIV-1 subtype among men who have sex with men with recent HIV-1 infection.
|
AIDS
|
2007
|
1.60
|
13
|
Implementation and evaluation of an HIV/STD intervention in Peru.
|
Eval Program Plann
|
2006
|
1.55
|
14
|
Vulnerability and sexual risks: Vagos and vaguitas in a low income town in Perú.
|
Cult Health Sex
|
2006
|
1.53
|
15
|
Test and tell: correlates and consequences of testing and disclosure of HIV status in South Africa (HPTN 043 Project Accept).
|
J Acquir Immune Defic Syndr
|
2009
|
1.53
|
16
|
Missed opportunities for HIV testing and late-stage diagnosis among HIV-infected patients in Uganda.
|
PLoS One
|
2011
|
1.50
|
17
|
Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay.
|
J Acquir Immune Defic Syndr
|
2009
|
1.46
|
18
|
Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection.
|
PLoS One
|
2011
|
1.46
|
19
|
Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease.
|
Br J Haematol
|
2011
|
1.45
|
20
|
Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).
|
Transfusion
|
2013
|
1.43
|
21
|
Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043).
|
PLoS One
|
2013
|
1.40
|
22
|
Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.
|
PLoS One
|
2013
|
1.24
|
23
|
Potential for false positive HIV test results with the serial rapid HIV testing algorithm.
|
BMC Res Notes
|
2012
|
1.24
|
24
|
Moderno love: sexual role-based identities and HIV/STI prevention among men who have sex with men in Lima, Peru.
|
AIDS Behav
|
2013
|
1.24
|
25
|
Looking to the future: South African men and women negotiating HIV risk and relationship intimacy.
|
Cult Health Sex
|
2011
|
1.22
|
26
|
Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial.
|
Haematologica
|
2008
|
1.18
|
27
|
Sexual risk and HIV prevention behaviours among African-American and Latino MSM social networking users.
|
Int J STD AIDS
|
2013
|
1.17
|
28
|
Mobile VCT: reaching men and young people in urban and rural South African pilot studies (NIMH Project Accept, HPTN 043).
|
AIDS Behav
|
2013
|
1.17
|
29
|
Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study.
|
Clin Infect Dis
|
2006
|
1.13
|
30
|
The HOPE social media intervention for global HIV prevention in Peru: a cluster randomised controlled trial.
|
Lancet HIV
|
2015
|
1.13
|
31
|
Effect of a community popular opinion leader HIV/STI intervention on stigma in urban, coastal Peru.
|
AIDS Behav
|
2011
|
1.11
|
32
|
Project HOPE: online social network changes in an HIV prevention randomized controlled trial for African American and Latino men who have sex with men.
|
Am J Public Health
|
2014
|
1.11
|
33
|
Pain as an emergent issue in thalassemia.
|
Am J Hematol
|
2010
|
1.10
|
34
|
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia.
|
Clin Ther
|
2007
|
1.06
|
35
|
Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major.
|
Br J Haematol
|
2008
|
1.05
|
36
|
[Influence of socio-cultural context on risk perception and negotiation of protection among poor homosexual males on the Peruvian coast].
|
Cad Saude Publica
|
2006
|
1.04
|
37
|
Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial.
|
AIDS Behav
|
2010
|
0.99
|
38
|
Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort.
|
Blood
|
2012
|
0.98
|
39
|
HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043).
|
BMC Infect Dis
|
2011
|
0.97
|
40
|
USING PARTICIPATORY METHODS AND GEOGRAPHIC INFORMATION SYSTEMS (GIS) TO PREPARE FOR AN HIV COMMUNITY-BASED TRIAL IN VULINDLELA, SOUTH AFRICA (Project Accept-HPTN 043).
|
J Community Psychol
|
2009
|
0.97
|
41
|
Iron chelation adherence to deferoxamine and deferasirox in thalassemia.
|
Am J Hematol
|
2011
|
0.93
|
42
|
Treating thalassemia major-related iron overload: the role of deferiprone.
|
J Blood Med
|
2012
|
0.92
|
43
|
Electrocardiographic consequences of cardiac iron overload in thalassemia major.
|
Am J Hematol
|
2011
|
0.91
|
44
|
Pain in thalassaemia: the effects of age on pain frequency and severity.
|
Br J Haematol
|
2012
|
0.91
|
45
|
Prevention of the sexual transmission of HIV-1: preparing for success.
|
J Int AIDS Soc
|
2008
|
0.90
|
46
|
Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome.
|
Hemoglobin
|
2004
|
0.89
|
47
|
Low-shear red blood cell oxygen transport effectiveness is adversely affected by transfusion and further worsened by deoxygenation in sickle cell disease patients on chronic transfusion therapy.
|
Transfusion
|
2012
|
0.89
|
48
|
Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC).
|
Pediatr Blood Cancer
|
2013
|
0.88
|
49
|
Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial.
|
Acta Haematol
|
2008
|
0.88
|
50
|
Antibody maturation and viral diversification in HIV-infected women.
|
PLoS One
|
2013
|
0.88
|
51
|
Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome.
|
Hemoglobin
|
2006
|
0.84
|
52
|
Response to Ronald Gray, Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda ( 2000, 14:2371-2381).
|
AIDS
|
2002
|
0.81
|
53
|
Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors.
|
AIDS Res Hum Retroviruses
|
2009
|
0.80
|
54
|
Quantitative computed tomography assessment of transfusional iron overload.
|
Br J Haematol
|
2011
|
0.79
|
55
|
Pulmonary hypertension does not affect the autonomic nervous system dysfunction of sickle cell disease.
|
Am J Hematol
|
2009
|
0.79
|
56
|
Predicting pituitary iron and endocrine dysfunction.
|
Ann N Y Acad Sci
|
2010
|
0.79
|
57
|
Iron chelation in thalassemia: time to reconsider our comfort zones.
|
Expert Rev Hematol
|
2011
|
0.78
|
58
|
Atrial dysfunction as a marker of iron cardiotoxicity in thalassemia major.
|
Haematologica
|
2008
|
0.78
|
59
|
Exercise performance in thalassemia major: correlation with cardiac iron burden.
|
Am J Hematol
|
2013
|
0.77
|
60
|
Combining two orally active iron chelators for thalassemia.
|
Ann Hematol
|
2010
|
0.77
|
61
|
Cobalamin C disease presenting with hemophagocytic lymphohistiocytosis.
|
Pediatr Hematol Oncol
|
2005
|
0.76
|
62
|
Moving the bar to the right place: positioning interventions in HIV prevention.
|
AIDS Behav
|
2014
|
0.75
|
63
|
Variance of pain prevalence and associated severity during the transfusion cycle of adult thalassaemia patients.
|
Br J Haematol
|
2014
|
0.75
|
64
|
Increased leucocyte apoptosis in transfused β-thalassaemia patients.
|
Br J Haematol
|
2012
|
0.75
|
65
|
Learning to Live With HIV in the Rural Townships: A Photovoice Study of Men Who Have Sex With Men Living With HIV in Mpumalanga, South Africa.
|
J Assoc Nurses AIDS Care
|
2017
|
0.75
|
66
|
Depression, gay men, and HIV acquisition.
|
Focus
|
2004
|
0.75
|